⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. NovoSeven® RT (coagulation Factor VIIa, recombinant) just got measured.
5/10 means NovoSeven® RT (coagulation Factor VIIa, recombinant) is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medication used to treat bleeding in hemophilia A or B with inhibitors, congenital FVII deficiency, and Glanzmann's thrombasthenia when platelets don't work, and adults with acquired hemophilia. See Safety Information and Prescribing Information.
Industry: Healthcare
novosevenrt.com2
Structured Data
6
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for NovoSeven® RT (coagulation Factor VIIa, recombinant).
Scored by Engagemii on June 27, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/novosevenrt
Cite this score: Engagemii (2026). "AEO Score for NovoSeven® RT (coagulation Factor VIIa, recombinant)." Retrieved from https://engagemii.com/aeo/brands/novosevenrt
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform